Protara Therapeutics, Inc. · NASDAQ:TARA
BlackRock, Inc. reported a 5.60% stake in Protara Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2025 · Filed Jul 17, 2025
BlackRock, Inc. reported a 5.60% stake in Protara Therapeutics, Inc., 2,143,880 shares, as a passive investor on Jun 30, 2025. Filed Jul 17, 2025 (Schedule 13G).
- Stake
- 5.60%
- Shares
- 2,143,880
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.60% | 2,143,880 |
Source
Related
- Protara Therapeutics, Inc.
- BlackRock, Inc.
- Protara Therapeutics, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Apr 27, 2026
- Schedule 13G/A · BlackRock, Inc. · Jan 21, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 7, 2026
- Form 4 · Shefferman Jesse · Jul 1, 2026
- Form 4 · Conkling William · Jun 3, 2026
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026